Sales value of cardiovascular system drugs in Italy 2011-2022
In Italy, the sales value of the cardiovascular system pharmaceutical products peaked in 2011, when it amounted to approximately 4.5 billion euros. Since then, there was a constant decline until 2019, when the sales value reached an all-time low of approximately 3.2 billion euros. Estimated data for 2022 showed a slight increase in revenue coming from these products. This statistic depicts the sales value of cardiovascular system pharmaceutical products in Italy from 2011 to 2022 (in million euros)